Adhera Therapeutics, Inc. (ATRX)

USD 0.0

(0.0%)

Market Cap (In USD)

722.00

Revenue (In USD)

-

Net Income (In USD)

-2.11 Million

Avg. Volume

1447.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.0E-4-0.043
PE
-
EPS
-1.17
Beta Value
-0.004
ISIN
US00687E4061
CUSIP
00687E109
CIK
737207
Shares
7220900.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Andrew Albert Kucharchuk M.B.A.
Employee Count
-
Website
https://adherathera.com
Ipo Date
1993-12-07
Details
Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.